Regeneron Pharmaceuticals (REGN) Q4 2013 Earnings

5NovConfirmed
Feb 13
May 13
Q3 2013
Q4 2013
0.79
0.94
1.1
1.25

Details

Expected EPS
N/A
Actual EPS
1.25
Surprise EPS
1.25
Surprise Percent
+∞%

Description

Regeneron Pharmaceuticals (REGN) has reported earnings of 1.25 per share for Q4 2013.

0 Comments

Share your thoughts